logo-loader
viewSativa Group PLC

Sativa Investments inks IP deal with Canada's Veritas Pharma

The company said it will use Veritas’ cannabis strain lead selection to assist its application to the Home Office Drugs Licensing and Compliance Unit for a medicinal cannabis growing licence

two sides shaking hands
Deal done: The agreement builds on a relationship cemented in May when Sativa invested C$200,000 in Veritas

Sativa Investments PLC (NEX:SATI) said it has signed an IP sharing agreement with Canada’s Veritas Pharma Inc, which it hopes will help its efforts in the UK’s emerging cannabis market.

The company said it will use Veritas’ cannabis strain lead selection to assist its application to the Home Office Drugs Licensing and Compliance Unit for a medicinal cannabis growing licence.

READ: Sativa Investments refines Orderly Market Agreements to improve liquidity for NEX traded shares

In May, Sativa invested C$200,000 in Veritas.

Chief executive, Geremy Thomas, said: "A key part of Sativa's strategy is to target overseas investments that can be leveraged to assist the company commercially as it participates in the industry in the UK and wider Europe.

“In this case, Veritas' scientific knowledge of seed selection will expedite a potential UK licence application to enable Sativa to grow cannabis strains for its own research and development purposes including use by recipients of grants awarded by the Sativa Foundation."

Quick facts: Sativa Group PLC

Price: 2.63 GBX

NEX:SATI
Market: NEX
Market Cap: -
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Sativa Group PLC named herein, including the promotion by the Company of Sativa Group PLC in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Sativa Investments PLC acquires UK-based PhytoVista Laboratories

Geremy Thomas, chief executive of Sativa Investments PLC (NEX:SATI), tells Proactive's Andrew Scott they've agreed to buy PhytoVista Laboratories, a UK-based lab that tests cannabis oils and hemp products, for £435,000. The British medicinal cannabis investment vehicle will pay £235,000...

on 4/7/18

2 min read